Skip to content

Evaluation of the ailing vocal fold reaction in response to electrical stimulation delivered on the ipsilateral thyroarytenoid (TA) muscle or the innervating branch of the Recurrent Laryngeal Nerve (RLN) in patients suffering from Unilateral Vocal Fold Paralysis (UVFP)

Evaluation of the ailing vocal fold reaction in response to electrical stimulation delivered on the ipsilateral thyroarytenoid (TA) muscle or the innervating branch of the Recurrent Laryngeal Nerve (RLN) in patients suffering from Unilateral Vocal Fold Paralysis (UVFP)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00020124
Enrollment
30
Registered
2020-01-08
Start date
2018-10-16
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J38.01

Interventions

Group 1: Intra-operative low voltage electrical stimulation directly delivered on the exposed TA muscle or innervating branch of the RLN ipsilateral to the ailing vocal fold in UVFP patients, during t

Sponsors

MED-EL Elektromedizinische Geräte GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: • Age = 18 • Diagnosed UVFP and scheduled for a routine surgery to treat UVFP symptoms (e.g. laryngeal framework surgery or reinnervation of the ailing VF) • Anatomic, physiological and mental conditions compatible with the participation in this • clinical investigation • High motivation with realistic expectations regarding the participation in this clinical investigation • Signed and dated informed consent before the start of any study specific assessment

Exclusion criteria

Exclusion criteria: • Lack of compliance with any inclusion criteria • Pregnant or breast-feeding women • Other clinical diseases that might result in alteration of the outcomes of this clinical investigation, in particular vocal fold-related disorders (e.g. cartilage arthroses), airwayrelated diseases (e.g. Asthma or COPD) or other muscular diseases • Use of an active implant • Known allergies or intolerance to the material used for this clinical investigation • Current participation in other drugs and/or medical device studies that can affect the results of the present clinical investigation • Anything that, in the opinion of the Principal Investigator, would place the subject at increased risk or preclude the subject's full compliance with the general requirements of this clinical investigation

Design outcomes

Primary

MeasureTime frame
Safety of the method measured by number of AEs, medialisation of the VF in reaction to stimulation observed using videolaryngoscopy

Secondary

MeasureTime frame
stimulation parameters used to determine the combination that elicits optimal vocal fold medialization; correlation between pre-OP laryngeal EMG (LEMG) data and optimal stimulation parameters

Countries

Germany

Contacts

Public ContactMarkus M. Hess

Deutsche Stimmklinik (im "Sepctrum" - auf dem Gelände des UKE)

hess@stimmklinik.de+49 405 13 13 007

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026